Position in ABEO
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$312,905
-$607,790 QoQ
Shares Held
69,845
-60.0% QoQ
Ownership
0.123%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ABEO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Pale Fire Capital SE holds $46,388,436 across 25 Biotechnology names. ABEO ranks #15 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MLYS |
Mineralys Therapeutics, Inc.
|
365,626 | $9,904,808 | |
| 2 | GERN |
Geron Corp
|
4,888,304 | $7,283,572 | |
| 3 | KURA |
Kura Oncology, Inc.
|
857,474 | $6,971,263 | |
| 4 | SNDX |
Syndax Pharmaceuticals Inc
|
284,460 | $6,644,985 | |
| 5 | RGNX |
REGENXBIO Inc.
|
493,726 | $4,137,423 | |
| 6 | GUTS |
Fractyl Health, Inc.
|
5,921,045 | $2,711,838 | |
| 7 | HRTX |
Heron Therapeutics, Inc. /De/
|
2,716,328 | $2,173,062 | |
| 8 | SGMT |
Sagimet Biosciences Inc.
|
221,875 | $1,159,296 |
All Filings in ABEO
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $312,905 | 69,845 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $920,695 | 174,705 | Shares | Defined | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||